Integral Diagnostics Ltd. ( (AU:IDX) ) has provided an update.
Integral Diagnostics Ltd. has announced a change in the director’s interest, with James Tobias Hall acquiring an additional 36,000 fully paid ordinary shares, bringing his total to 189,552 shares. This on-market trade reflects a potential increase in confidence or strategic positioning by the director, which could impact stakeholder perceptions and the company’s market standing.
More about Integral Diagnostics Ltd.
Integral Diagnostics Ltd. operates in the healthcare industry, providing diagnostic imaging services. The company focuses on delivering high-quality medical imaging services across various regions, catering to the needs of healthcare professionals and patients.
YTD Price Performance: -26.80%
Average Trading Volume: 1,577,182
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$792M
Find detailed analytics on IDX stock on TipRanks’ Stock Analysis page.